Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Brian Chia

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
ACS Medicinal Chemistry Letters|January 19, 2023
Novel PSMA-Targeting Radionuclide Peptidomimetics for Treating Prostate CancerC S Brian Chia
ACS Medicinal Chemistry Letters|March 16, 2022
Novel Nitrile Peptidomimetics for Treating COVID-19C S Brian Chia
ACS Medicinal Chemistry Letters|September 15, 2022
Oral Nonpeptidic, Noncovalent Triazine Coronavirus Main Protease Inhibitors for Treating COVID-19C S Brian Chia, Masafumi Inoue
ACS Medicinal Chemistry Letters|September 15, 2022
Novel Coronavirus Main Protease Di- and Tripeptide Inhibitors for Treating COVID-19C S Brian Chia, Yi Yang See
ACS Medicinal Chemistry Letters|June 16, 2022
Novel Halomethylketone Azadipeptides for Treating COVID-19C S Brian Chia, Yi Yang See
Chemmedchem|May 29, 2023
A Patent Review on SARS Coronavirus Papain-Like Protease (PL<sup>pro</sup> ) InhibitorsC S Brian Chia, Siew Pheng Lim
Chemmedchem|October 15, 2021
A Patent Review on SARS Coronavirus Main Protease (3CL<sup>pro</sup> ) InhibitorsC S Brian Chia, Weijun Xu, Pearly Shuyi Ng
Frontiers in Chemistry|February 23, 2018
Editorial: Antimicrobial and Anticancer PeptidesNeil M O'Brien-Simpson, Ralf Hoffmann, C S Brian Chia, et al.
Biopolymers|June 22, 2010
Membrane binding and perturbation studies of the antimicrobial peptides caerin, citropin, and maculatinC S Brian Chia, Yujing Gong, John H Bowie, et al.
Chemical Biology & Drug Design|April 15, 2024
Cytotoxic activity and cell specificity of a novel LHRH peptide drug conjugate, D-Cys6-LHRH vedotin, against ovarian cancer cell linesSubramanyam Vankadara, Zhiyuan Ke, Sifang Wang, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
ACS Medicinal Chemistry Letters|January 19, 2023
Novel PSMA-Targeting Radionuclide Peptidomimetics for Treating Prostate CancerC S Brian Chia
ACS Medicinal Chemistry Letters|March 16, 2022
Novel Nitrile Peptidomimetics for Treating COVID-19C S Brian Chia
ACS Medicinal Chemistry Letters|September 15, 2022
Oral Nonpeptidic, Noncovalent Triazine Coronavirus Main Protease Inhibitors for Treating COVID-19C S Brian Chia, Masafumi Inoue
ACS Medicinal Chemistry Letters|September 15, 2022
Novel Coronavirus Main Protease Di- and Tripeptide Inhibitors for Treating COVID-19C S Brian Chia, Yi Yang See
ACS Medicinal Chemistry Letters|June 16, 2022
Novel Halomethylketone Azadipeptides for Treating COVID-19C S Brian Chia, Yi Yang See
Chemmedchem|May 29, 2023
A Patent Review on SARS Coronavirus Papain-Like Protease (PL<sup>pro</sup> ) InhibitorsC S Brian Chia, Siew Pheng Lim
Chemmedchem|October 15, 2021
A Patent Review on SARS Coronavirus Main Protease (3CL<sup>pro</sup> ) InhibitorsC S Brian Chia, Weijun Xu, Pearly Shuyi Ng
Frontiers in Chemistry|February 23, 2018
Editorial: Antimicrobial and Anticancer PeptidesNeil M O'Brien-Simpson, Ralf Hoffmann, C S Brian Chia, et al.
Biopolymers|June 22, 2010
Membrane binding and perturbation studies of the antimicrobial peptides caerin, citropin, and maculatinC S Brian Chia, Yujing Gong, John H Bowie, et al.
Chemical Biology & Drug Design|April 15, 2024
Cytotoxic activity and cell specificity of a novel LHRH peptide drug conjugate, D-Cys6-LHRH vedotin, against ovarian cancer cell linesSubramanyam Vankadara, Zhiyuan Ke, Sifang Wang, et al.
Pageof 3